| Literature DB >> 25677332 |
Lan Ye1,2,3, Tsuyoshi Hamaguchi1,3, Sarah K Fritschi1,2,3, Yvonne S Eisele1,3, Ulrike Obermüller1,3, Mathias Jucker1,3, Lary C Walker1,4,5.
Abstract
An important early event in the pathogenesis of Alzheimer's disease (AD) is the aberrant polymerization and extracellular accumulation of amyloid-β peptide (Aβ). In young transgenic mice expressing the human Aβ-precursor protein (APP), deposits of Aβ can be induced by the inoculation of minute amounts of brain extract containing Aβ aggregates ("Aβ seeds"), indicative of a prion-like seeding phenomenon. Moreover, focal intracerebral injection of Aβ seeds can induce deposits not only in the immediate vicinity of the injection site, but, with time, also in distal regions of the brain. However, it remains uncertain whether the spatial progression of Aβ deposits occurs via nonsystematic diffusion from the injection site to proximal regions or via directed transit along neuroanatomical pathways. To address this question, we analyzed the spatiotemporal emergence of Aβ deposits in two different APP-transgenic mouse models that had been previously inoculated with Aβ seeds into the hippocampal formation. The results revealed a specific, neuroanatomically constrained pattern of induced Aβ deposits in structures corresponding to the limbic connectome, supporting the hypothesis that neuronal pathways act as conduits for the movement of proteopathic agents among brain regions, thereby facilitating the progression of disease.Entities:
Keywords: Alzheimer; hippocampus; neurodegeneration; prion; transgenic mice
Mesh:
Substances:
Year: 2015 PMID: 25677332 PMCID: PMC4530099 DOI: 10.1111/bpa.12252
Source DB: PubMed Journal: Brain Pathol ISSN: 1015-6305 Impact factor: 6.508